Texas Oncology P.A. — Dallas, Texas

Texas Oncology P.A. is a clinical research site located in Dallas, Texas, United States 75203.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology P.A. has participated in 8 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Myelodysplastic Syndromes, Colorectal Cancer.

Sponsors: Eli Lilly and Company, Genzyme, a Sanofi Company, Sanofi.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology P.A.?

Texas Oncology P.A. has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology P.A. conducted?

Texas Oncology P.A. has 8 clinical trials on record. Their work covers Metastatic Breast Cancer, Myelodysplastic Syndromes, Colorectal Cancer.

Is Texas Oncology P.A. accredited by Crixeo Health?

Yes — Texas Oncology P.A. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology P.A.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.